MedTrace Logo

Spectral Domain Optical Coherence Tomography Analysis for Glaucoma

NCT01612416 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 169

Last updated 2012-06-05

No results posted yet for this study

Summary

The aim of this study is to examine whether there is a difference in macular ganglion cell complex thickness and retinal nerve fiber layer thickness in early-stage Primary open angle glaucoma and normal tension glaucoma with spectral domain OCT.

Conditions

  • GLAUCOMA 1, OPEN ANGLE, D (Disorder)

Interventions

DEVICE

RS-3000 OCT measurements

Ganglion cell, retinal nerve fiber layer and retinal thickness measurements of normal subjects, primary open angle glaucoma and normal tension glaucoma patients using RS-3000 OCT RetinaScan

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Penpe G Firat, M.D. · Assistant Professor

  • Selim Doganay, M.D · Professor

  • Ersan E Demirel, M.D. · Resident

  • Cemil Colka, M.D. · Associate Professor

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
28 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01612416 on ClinicalTrials.gov